Role of VEGF and matrix metalloproteinase-9 in peritumoral brain edema associated with supratentorial benign meningiomas

Neuropathology

Volumn 32, Issue 6, 2012, Pages 638-646

  Iwado, Eiji ^a   Ichikawa, Tomotsugu ^a   Kosaka, Hiroshi ^a   Otsuka, Shinji ^a   Kambara, Hirokazu ^a   Tamiya, Takashi ^b   Kondo, Seiji ^c   Date, Isao ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Matrix metalloproteinase 9; Meningioma; Peritumoral brain edema; Pial blood supply; Vascular endothelial growth factor

Indexed keywords

GELATINASE B; VASCULOTROPIN;

ADULT; AGED; ARACHNOID; ARTICLE; BRAIN BLOOD FLOW; BRAIN EDEMA; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PERITUMORAL BRAIN EDEMA; PIAL BLOOD SUPPLY; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; BRAIN EDEMA; BRAIN NEOPLASMS; CEREBRAL ANGIOGRAPHY; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MENINGIOMA; MIDDLE AGED; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 84870061060     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2012.01312.x     Document Type: Article

References (40)

1. Bitzer M, Wockel L, Morgalla M etal. Peritumoural brain oedema in intracranial meningiomas: influence of tumour size, location and histology. Acta Neurochir (Wien) 1997; 139: 1136-1142.
2. Bitzer M, Wockel L, Luft AR etal. The importance of pial blood supply to the development of peritumoral brain edema in meningiomas. J Neurosurg 1997; 87: 368-373.
3. Tamiya T, Ono Y, Matsumoto K, Ohmoto T. Peritumoral brain edema in intracranial meningiomas: effects of radiological and histological factors. Neurosurgery 2001; 49: 1046-1052.
4. Lobato RD, Alday R, Gomez PA etal. Brain oedema in patients with intracranial meningioma. Correlation between clinical, radiological, and histological factors and the presence and intensity of oedema. Acta Neurochir (Wien) 1996; 138: 485-494.
5. Alvarez F, Roda JM, Romero MP, Morales C, Sarmiento MA, Blazquez MG. Malignant and atypical meningiomas: a reappraisal of clinical, histological, and computed tomographic features. Neurosurgery 1987; 20: 688-694.
6. Constantini S, Tamir J, Gomori MJ, Shohami E. Tumor prostaglandin levels correlate with edema around supratentorial meningiomas. Neurosurgery 1993; 33: 204-210.
7. De Vries J, Wakhloo AK. Cerebral oedema associated with WHO-I, WHO-II, and WHO-III-meningiomas: correlation of clinical, computed tomographic, operative and histological findings. Acta Neurochir (Wien) 1993; 125: 34-40.
8. Maiuri F, Gangeni M, Cirillo S etal. Cerebral edema associated with meningiomas. Surg Neurol 1987; 27: 64-68.
9. Philippon J, Foncin JF, Grob R, Srour A, Poisson M, Pertuiset BF. Cerebral edema associated with meningiomas: possible role of a secretory-excretory phenomenon. Neurosurgery 1984; 14: 295-301.
10. Yoshioka H, Hama S, Taniguchi E, Sugiyama K, Arita K, Kurisu K. Peritumoral brain edema associated with meningioma: influence of vascular endothelial growth factor expression and vascular blood supply. Cancer 1999; 85: 936-944.
11. Pistolesi S, Fontanini G, Camacci T etal. Meningioma-associated brain oedema: the role of angiogenic factors and pial blood supply. J Neurooncol 2002; 60: 159-164.
12. Bitzer M, Topka H, Morgalla M, Frise S, Wockel L, Voigt K. Tumor-related venous obstruction and development of peritumoral brain edema in meningiomas. Neurosurgery 1998; 42: 730-737.
13. Benzel EC, Gelder FB. Correlation between sex hormone binding and peritumoral edema in intracranial meningiomas. Neurosurgery 1988; 23: 169-174.
14. Maiuri F, Montagnani S, Ianconetta G, Gallicchio B, Bernardo A, Signorelli F. Correlation between sex hormone receptors and peritumoral edema in intracranial meningiomas. J Neurosurg Sci 1994; 38: 29-33.
15. Kalkanis SN, Carroll RS, Zhang J, Zamani AA, Black PM. Correlation of vascular endothelial growth factor messenger RNA expression with peritumoral vasogenic cerebral edema in meningiomas. J Neurosurg 1996; 85: 1095-1101.
16. Goldman CK, Bharara S, Palmer CA etal. Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression. Neurosurgery 1997; 40: 1269-1277.
17. Provias J, Claffey K, delAguila L, Lau N, Feldkamp M, Guha A. Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema. Neurosurgery 1997; 40: 1016-1026.
18. Bitzer M, Opitz H, Popp J etal. Angiogenesis and brain oedema in intracranial meningiomas: influence of vascular endothelial growth factor. Acta Neurochir (Wien) 1998; 140: 333-340.
19. Otsuka S, Tamiya T, Ono Y etal. The relationship between peritumoral brain edema and the expression of vascular endothelial growth factor and its receptors in intracranial meningiomas. J Neurooncol 2004; 70: 349-357.
20. Okada M, Miyake K, Matsumoto Y, Kawai N, Kunishio K, Nagao S. Matrix metalloproteinase-2 and matrix metalloproteinase-9 expressions correlate with the recurrence of intracranial meningiomas. J Neurooncol 2004; 66: 29-37.
21. Nordqvist AC, Smurawa H, Mathiesen T. Expression of matrix metalloproteinases 2 and 9 in meningiomas associated with different degrees of brain invasiveness and edema. J Neurosurg 2001; 95: 839-844.
22. Paek SH, Kim CY, Kim YY etal. Correlation of clinical and biological parameters with peritumoral edema in meningioma. J Neurooncol 2002; 60: 235-245.
23. Barresi V, Vitareli E, Tuccari G, Barresi G. MMP-9 expression in meningiomas: a prognostic marker for recurrence risk? J Neurooncol 2011; 102: 189-196.
24. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999; 274: 21491-21494.
25. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92: 827-839.
26. Mott JD, Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 2004; 16: 558-564.
27. Westermarck J, Kahari VM. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 1999; 13: 781-792.
28. Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 2000; 10: 415-433.
29. Rao JS, Steck PA, Mohanam S, Stetler-Stevenson WG, Liotta LA, Sawaya R. Elevated levels of M(r) 92, 000 type IV collagenase in human brain tumors. Cancer Res 1993; 53: 2208-2211.
30. Nakagawa T, Kubota T, Kabuto M etal. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 1994; 81: 69-77.
31. Yong VW, Krekoski CA, Forsyth PA, Bell R, Edwards DR. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci 1998; 21: 75-80.
32. Sawaya RE, Yamamoto M, Gokaslan ZL etal. Expression and localization of 72kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin Exp Metastasis 1996; 14: 35-42.
33. von Randow AJ, Schindler S, Tews DS. Expression of extracellular matrix-degrading proteins in classic, atypical, and anaplastic meningiomas. Pathol Res Pract 2006; 202: 365-372.
34. Lamszus K, Lengler U, Schmidt NO, Stavrou D, Ergün S, Westphal M. Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy. Neurosurgery 2000; 46: 938-947.
35. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumours of the Central Nervous System. Lyon: IARC, 2007.
36. Sindou MP, Alaywan M. Role of pia mater vascularization of the tumour in the surgical outcome of intracranial meningiomas. Acta Neurochir (Wien) 1994; 130: 90-93.
37. Das A, Tan WL, Smith DR. Expression of extracellular matrix markers in benign meningiomas. Neuropathology 2003; 23: 275-281.
38. Mizoue T, Kawamoto H, Arita K, Tominaga A, Kurisu K. Secretion of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by meningiomas detected by cell immunoblot analysis. Acta Neurochir (Wien) 1999; 141: 481-486.
39. Bergers G, Brekken R, McMahon G etal. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000; 2: 737-744.
40. Chandrasekar N, Jasti S, Alfred-Yung WK etal. Modulation of endothelial cell morphogenesis in vitro by MMP-9 during glial-endothelial cell interactions. Clin Exp Metastasis 2000; 18: 337-342.